PRE — Prenetics Global Ltd
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1876431 ·
Last close
$18.64
Market Cap
$287.42M
52W High
$22.75
52W Low
$14.00
ADV30
205,822
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 35,954,000 | 23,283,000 | -9,706,000 | -23,104,000 | 175,302,000 | 56,017,000 | 54,280,000 |
| Dec 2025 | 36,558,000 | 21,588,000 | -13,136,000 | -7,501,000 | 206,073,000 | 32,131,000 | 49,707,000 |
| Sep 2025 | 23,555,000 | 14,024,000 | -6,559,000 | -7,408,000 | 196,507,000 | 13,264,000 | 35,305,000 |
| Jun 2025 | 17,680,000 | 7,289,000 | -9,869,000 | -12,410,000 | 199,106,000 | 17,249,000 | 48,214,000 |
Balance + Analyst (yfinance extras)
Retained Earnings
$-554,781,000
Inventory
$7,032,000
Receivables
$4,294,000
ST Investments
$31,192,000
EBIT TTM
$-38,230,000
Pretax Income TTM
$-38,464,000
Interest Exp TTM
$234,000
Analysts
4
Yahoo Snapshot (yfinance, live)
Total Revenue
$120,069,000
EBITDA
$-40,821,000
Free Cash Flow
$-84,654,752
Enterprise Value
$211,727,744
Total Cash
$115,381,000
Total Debt
$457,000
Shares Out
15,419,419
Trailing EPS
$-3.63
Book Value
$7.13
ROE
-40.8%
ROA
-13.5%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 92,390,000 | -38,129,000 | -37,709,000 | 206,073,000 | 49,707,000 | — | -21,826,000 |
| Dec 2024 | 15,936,000 | -38,277,000 | -46,304,000 | 213,575,000 | 42,229,000 | — | -28,874,000 |
| Dec 2023 | 6,155,000 | -42,469,000 | -62,724,000 | 254,171,000 | 44,013,000 | — | -13,765,000 |
| Dec 2022 | 13,164,000 | -65,917,000 | -190,454,000 | 312,131,231 | 68,668,371 | — | 14,515,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.95
Max Pain — expiry 2026-08-21 (volume-derived — Yahoo OI feed degraded)
max pain strike: $17.50 · spot: $18.64 · call volume: 156 · put volume: 17
Expected Move to 2026-08-21:
±$4.13
(22.16%) —
implied range
$14.51 –
$22.77
· ATM straddle on $17.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| PRLD | Prelude Therapeutics Inc | $298.62M | $4.60 | — |
| AMRN | AMARIN CORP PLC\UK | $299.02M | $14.26 | — |
| LYEL | Lyell Immunopharma, Inc. | $301.94M | $12.94 | — |
| ORGO | Organogenesis Holdings Inc. | $304.96M | $2.37 | — |
| IRD | Opus Genetics, Inc. | $306.32M | $3.71 | — |
News headlines (Yahoo Finance, 1h cache)
PRE Continues to Exceed Expectations and Receive Preferential Financing
2026-07-15 12:05 · Yahoo
Sector Update: Healthcare Stocks Fall Late Afternoon
2026-07-14 19:46 · Yahoo
Prenetics’ IM8 Secures $1 Billion Growth Financing from General Catalyst’s Customer Value Fund (CVF)
2026-07-14 17:35 · Yahoo
Prenetics Global Limited (PRE) Receives Bullish Coverage as IM8 Targets Supplement Market Growth
2026-06-25 12:43 · Yahoo
CEO Chat with Danny Yeung, Co-Founder and CEO of Prenetics Global
2026-06-23 16:54 · Yahoo
Sector Update: Healthcare Stocks Decline Late Afternoon
2026-06-10 19:33 · Yahoo
PRE Continues to Post Rapid Growth
2026-06-10 11:10 · Yahoo
Prenetics Appoints Hudson Leogrande, Founder and CEO of Multi-Billion-Dollar DTC Brand Comfrt, to Board of Directors as IM8 Accelerates TikTok and Meta Expansion
2026-06-04 12:30 · Yahoo
Prenetics Starts Partnership with Jay Shetty as IM8 Global Ambassador & Shareholder
2026-05-20 20:51 · Yahoo
Prenetics Announces Jay Shetty as IM8 Global Ambassador and Shareholder in Multi-Year Partnership
2026-05-20 12:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.